<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64251</article-id><article-id pub-id-type="doi">10.7554/eLife.64251</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Time resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-213082"><name><surname>Vemulapalli</surname><given-names>Vidyasiri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213083"><name><surname>Chylek</surname><given-names>Lily A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213084"><name><surname>Erickson</surname><given-names>Alison</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213085"><name><surname>Pfeiffer</surname><given-names>Anamarija</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213086"><name><surname>Gabriel</surname><given-names>Khal-Hentz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213087"><name><surname>LaRochelle</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-115436"><name><surname>Subramanian</surname><given-names>Kartik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6900-8882</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-230200"><name><surname>Cao</surname><given-names>Ruili</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118828"><name><surname>Stegmaier</surname><given-names>Kimberley</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213151"><name><surname>Mohseni</surname><given-names>Morvarid</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-213152"><name><surname>LaMarche</surname><given-names>Matthew J</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-213088"><name><surname>Acker</surname><given-names>Michael G</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-6654"><name><surname>Sorger</surname><given-names>Peter K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3364-1838</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13119"><name><surname>Gygi</surname><given-names>Steven P</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-31476"><name><surname>Blacklow</surname><given-names>Stephen C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6904-1981</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biological Chemistry and Molecular Pharmacology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Systems Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Cell Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Center for Protein Research</institution>, <institution>Novo Nordisk Foundation and University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff5"><institution content-type="dept">Department of Systems Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Broad Institute of Harvard and MIT</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Oncology</institution>, <institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Global Discovery Chemistry</institution>, <institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Department of Cell Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-138279"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Reviewing editor</role><aff><institution>Fred Hutchinson Cancer Research Centre</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>stephen_blacklow@hms.harvard.edu</email> (SB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>03</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64251</elocation-id><history><date date-type="received"><day>23</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Vemulapalli et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Vemulapalli et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64251-v1.pdf"/><abstract><p>SHP2 is a protein tyrosine phosphatase that normally potentiates intracellular signaling by growth factors, antigen receptors, and some cytokines, yet is frequently mutated in human cancer. Here, we examine the role of SHP2 in the responses of breast cancer cells to EGF by monitoring phosphoproteome dynamics when SHP2 is allosterically inhibited by SHP099. The dynamics of phosphotyrosine abundance at more than 400 tyrosine residues reveal six distinct response signatures following SHP099 treatment and washout. Remarkably, in addition to newly identified substrate sites on proteins such as occludin, ARHGAP35, and PLCγ2, another class of sites shows reduced phosphotyrosine abundance upon SHP2 inhibition. Sites of decreased phospho-abundance are enriched on proteins with two nearby phosphotyrosine residues, which can be directly protected from dephosphorylation by the paired SH2 domains of SHP2 itself. These findings highlight the distinct roles of the scaffolding and catalytic activities of SHP2 in effecting a transmembrane signaling response.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100015311</institution-id><institution>Novartis Institutes for BioMedical Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Vemulapalli</surname><given-names>Vidyasiri</given-names></name><name><surname>Gabriel</surname><given-names>Khal-Hentz</given-names></name><name><surname>LaRochelle</surname><given-names>Jonathan</given-names></name><name><surname>Stegmaier</surname><given-names>Kimberley</given-names></name><name><surname>Blacklow</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R35 CA220340</award-id><principal-award-recipient><name><surname>Blacklow</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>U54-HL127365</award-id><principal-award-recipient><name><surname>Chylek</surname><given-names>Lily A</given-names></name><name><surname>Sorger</surname><given-names>Peter K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Morvarid Mohseni, Novartis employee while this work was performed..</p></fn><fn fn-type="conflict" id="conf3"><p>Matthew J LaMarche, Novartis employee while this work was performed..</p></fn><fn fn-type="conflict" id="conf4"><p>Michael G Acker, Novartis employee while this work was performed..</p></fn><fn fn-type="conflict" id="conf5"><p>Stephen C Blacklow, SCB receives research funding for this project from Novartis, is a member of the SAB of Erasca, Inc., is an advisor to MPM Capital, and is a consultant on unrelated projects for IFM, Scorpion Therapeutics, and Ayala Therapeutics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Quantitative proteomics data have been deposited in the mass spectrometry interactive virtual environment (MassIVE) database with the accession code MSV000083702. All other data generated in this study are in the manuscript and supporting files.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Vidyasiri Vemulapalli</collab><collab>Alison R. Erickson</collab><collab>Steven P. Gygi</collab><collab>Stephen C. Blacklow</collab></person-group><year iso-8601-date="2021">2021</year><source>Time resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/doi:10.25345/C5HS6C">https://doi.org/doi:10.25345/C5HS6C</ext-link><comment>MassIVE MSV000083702</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-64251-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>